Navigation Links
European Multidisciplinary Conference on Thoracic Oncology
Date:3/4/2009

The European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS) are pleased to announce the first European Multidisciplinary Conference on Thoracic Oncology (EMCTO).

This meeting will provide a comprehensive update and a multidisciplinary perspective of state-of-the-art on the prevention, screening, diagnosis, and treatment of chest tumors, including results of translational research. It will facilitate scientific and clinical exchange, with the aim of promoting an integrated approach to diagnosis, treatment and management of thoracic cancers.

Thoracic cancers are globally recognized as a major cause of mortality. Combating their causes, developing better methods for early detection, advancing research, and improving treatments, require the collaboration of many research and clinical specialties.

Organized in partnership between the European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS), the conference is designed to provide healthcare professionals with a comprehensive update and a multidisciplinary perspective of state-of-the-art management of patients with thoracic malignancies, including the role of new technologies and the necessary collaboration between various medical specialties.

By bringing together authoritative European partners in thoracic oncology, EMCTO represents an excellent opportunity to promote an integrated approach to diagnosis and treatment of chest tumors and to strengthen European cooperation and scientific exchange .

Meeting highlights:

  • New developments in understanding lung cancer biology
  • Prognostic and predictive factors in non-small-cell lung cancer
  • Critical appraisal of imaging tools in thoracic oncology
  • Individualized staging: practical implications
  • Heterogeneity of locally advanced lung cancer and its implications for treatment
  • Chemoradiotherapy and new developments in radiotherapy
  • Neuroendocrine tumors, mesothelioma and thymoma
  • Individualized therapy based on tumor features
  • Elderly and co-morbid patients
  • Future developments in multidisciplinary treatments

Among the top international experts who have contributed to this multidisciplinary conference: Rolf Stahel, Switzerland; Robert Pirker, Austria; David Gandara, US; Enriqueta Felip, Spain; Giorgio Scagliotti, Italy; Franoise Mornex, France; Paris Kosmidis, Greece; Michael Cullen, UK; Jean-Paul Sculier, Belgium; Cesare Gridelli, Italy; Walter Weder, Switzerland

Meeting venue

The European Multidisciplinary Conference in Thoracic Oncology (EMCTO) will take place at the Palazzo dei Congressi, Lugano.

Services for media representatives

A fully equipped press room will be in operation at the conference with Internet access and telephone lines for registered reporters. You will have access to all the scientific sessions and the possibility to schedule one-on-one interviews with top speakers and presenters of the studies, both in presence and remotely. Please contact the ESMO Communication Dept. at media@esmo.org to already find out about the preliminary timetable or to book a telephone hook up. The conference full program is available at http://www.esmo.org/newsroom/events/

Media registration

To register for the conference as a media representative, please visit http://www.esmo.org/newsroom/events/ and send the Complimentary Media Registration form to the ESMO Communication Department.

Accommodation

For hotel reservation, please visit: http://www.esmo.org/events/lung-2009/book-hotel.html


'/>"/>
Contact: ESMO Press Office
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. 2 French scientists win European award for communication
3. Three-way mating game of North American lizard found in distant European relative
4. European lead in reading past climates from ice cores
5. Hot spots the key to controlling European carp in Australia
6. IdentiPHI Opens Paris Office to Boost European Sales and Support
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. First European Lung Cancer Conference
9. ESFs European ice core project EPICA receives prestigious Descartes Prize
10. European membrane expertise to focus on new treatments for human diseases
11. European light research opens door for optical storage and computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile ... smartphone prices have dropped dramatically. The quarterly average price ... 2013 to $276 in Q4 2016.  There are now ... price of $116, up from just 28 a year ... According to Maxine Most , Acuity Market ...
(Date:1/19/2017)... 2017 Sensory Inc ., a ... for consumer electronics, and i nnerCore ... cybersecurity solutions, today announced a global partnership that ... worldwide to bolster security of data sensitive mobile ... authentication platforms they offer, innerCore now offers its ...
(Date:1/13/2017)... Jan. 13, 2017 Sandata Technologies, LLC, ... the homecare industry, including Electronic Visit Verification™ (EVV™), ... Justin Jugs, as Senior Vice President of Product ... years of homecare experience to Sandata, where he ... plans to align Sandata,s suite of solutions with ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... , Feb 22, 2017 ... of the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By ... (2016-2021)" report to their offering. ... Global Biological Crop Protection Market is forecasted ... The strong growth in biopesticide or biological crop protection market ...
(Date:2/22/2017)... 2017 Aethlon Medical, Inc. (Nasdaq: ... that validated the ability of the Aethlon Hemopurifier® to ... mortality in immune-suppressed sepsis patients and also contribute to ... objective of the study was to validate the ... (EBV) and Herpes Simplex virus 1 (HSV1) by the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech ... as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins ... Pennside after more than a decade with leading market research firm, GfK. He ...
(Date:2/22/2017)... TRIANGLE PARK, N.C., Feb. 22, 2017  United Therapeutics ... its financial results for the fourth quarter and ... 2016 financial results reflect continued growth as net ... million," said Martine Rothblatt, Ph.D., United Therapeutics, Chairman ... our ability to develop and advance our growing ...
Breaking Biology Technology: